Share this
Vaccines and the Law
Chambers Associate • August 11, 2021
Cooley Joins the Boston Bar Association as Newest Sponsor Firm
Boston Bar Association • June 7, 2021
NYLPI Nonprofit Toolkit: Intellectual Property Manual
New York Lawyers for the Public Interest • August 3, 2020
Scholar Rock – $86 Million IPO
June 18, 2018
Cooley Advises on Nightstar + NuCana IPOs
Pair of transactions highlight strength across life sciences sector public offerings • October 10, 2017
Zealand Pharma – $89 Million IPO
August 25, 2017
SoftBank Vision Fund Leads $1.1 Billion Financing of Roivant Sciences
August 14, 2017
Ovid – $75 Million IPO
June 13, 2017
Cooley Advises on Series of Life Sciences IPOs
Zymeworks, Verona, UroGen and Biohaven IPOs highlight core strengths across the sector • May 30, 2017
ZIOPHARM Oncology – $50 Million Offering
May 17, 2017
Myovant Raises $218 Million in Largest Biotech IPO of Year
October 31, 2016
Novan – $52 Million IPO
October 14, 2016
Recro Pharma – $15 Million Follow-On
August 30, 2016
Syros IPO – $58 Million
July 26, 2016
Minerva – $58 Million Follow-On Offering
July 7, 2016
Movers & Shakers: Heidi Erlacher
Diversity & the Bar • March 1, 2016
Heidi Erlacher Named Partner in Charge of Cooley's Boston Office
January 4, 2016
WAVE Life Sciences – IPO
December 7, 2015
Cooley Launches Patent Practice in London
August 3, 2015
Axovant Completes $362 Million IPO
June 16, 2015
Cooley Expands National IP Practice, Adds Leading Life Sciences Patent Group
April 2, 2014
Cooley Expands National IP Practice, Adds Leading Life Sciences Patent Group – Media
Bloomberg News, The American Lawyer, Boston Business Journal, Law360, etc. • April 2, 2014